Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas Paul Vander Woude, M.D.

Concepts (15)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neurofibromatosis 1120245610.160 Why?
Tumor Suppressor Protein p531202429250.110 Why?
Drug Resistance, Neoplasm1202452140.080 Why?
Protein Kinase Inhibitors1202456350.070 Why?
Neurofibrosarcoma12024260.060 Why?
Neurofibromin 1120241900.050 Why?
Nerve Sheath Neoplasms120241670.050 Why?
Proto-Oncogene Proteins c-met120245670.040 Why?
Cell Lineage1202425240.030 Why?
TOR Serine-Threonine Kinases1202420610.030 Why?
Cell Line, Tumor12024168710.020 Why?
Signal Transduction12024233620.010 Why?
Mice12024811380.010 Why?
Animals120241678380.010 Why?
Humans120247592550.000 Why?
Vander Woude's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.